Inventiva (IVA) Net Cash Flow (2019 - 2025)
Inventiva's (IVA) quarterly Net Cash Flow came in at $93.6 million in Q2 2025, up 279.71% year-on-year from $24.6 million in Q2 2024, and up 279.71% quarter-over-quarter from -$52.1 million in Q2 2024.
Inventiva (IVA) Net Cash Flow (2019 - 2025) Analysis & Trends
Inventiva's Net Cash Flow history runs 6 years deep, the most recent figure standing at $93.6 million for Q2 2025.
- On a quarterly basis, Net Cash Flow rose 279.71% year-over-year to $93.6 million in Q2 2025; TTM through Dec 2025 was $41.5 million, a 179.71% increase from a year earlier, with the FY2025 full-year figure at $3.7 million, down 94.88% from the prior year.
- Net Cash Flow improved to $93.6 million in Q2 2025 per IVA's latest filing, from -$52.1 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $93.6 million in Q2 2025 and bottomed at -$52.1 million in Q2 2024.
- The 4-year median for Net Cash Flow is -$13.1 million (2022), against an average of -$2.8 million.
- Across the five-year window, Net Cash Flow plunged 332.96% in 2021 and jumped 279.71% in 2025, its largest moves.
- Year by year, Net Cash Flow stood at -$17.2 million in 2021, then increased by 25.56% to -$12.8 million in 2022, then plunged by 307.0% to -$52.1 million in 2024, then soared by 279.71% to $93.6 million in 2025.
- Per Business Quant, the three latest IVA Net Cash Flow figures stand at $93.6 million (Q2 2025), -$52.1 million (Q2 2024), and -$12.8 million (Q4 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 93.56 Mn |
| Jun 30, 2025 | 93.56 Mn |
| Jun 30, 2024 | -52.06 Mn |
| Jun 30, 2024 | -52.06 Mn |
| Dec 31, 2022 | -12.79 Mn |
| Dec 31, 2022 | -12.79 Mn |
| Sep 22, 2022 | -13.08 Mn |
| Sep 22, 2022 | -13.08 Mn |
| Dec 31, 2021 | -17.18 Mn |
| Dec 31, 2021 | -17.18 Mn |
| Jun 30, 2021 | -16.38 Mn |
| Jun 30, 2021 | -16.38 Mn |
| Mar 31, 2021 | -1.72 Mn |
| Mar 31, 2021 | -1.72 Mn |
| Dec 31, 2020 | 19.59 Mn |
| Dec 31, 2020 | 19.59 Mn |
| Jun 30, 2020 | 7.03 Mn |
| Jun 30, 2020 | 7.03 Mn |
| Mar 31, 2020 | 12.20 Mn |
| Mar 31, 2020 | 12.20 Mn |